Psychiatric Neuromodulation Unit (PNU)

Organisational unit: Research group

Research

Our research group investigates underlying mechanisms and treatments for depression. The most efficient treatment for severe depression is electroconvulsive therapy (ECT). In collaboration with Danish researchers, we were the first to demonstrate that the generation of new blood vessels and nerve cells in the brain increase after ECT. Others have subsequently shown that all antidepressant (AD) treatments exert these effects, and it is believed that plasticity in neural circuits is crucial for the AD effect. We now conduct a multicenter study where the AD and cognitive effects of ECT are compared to those of ketamine. Ketamine is an analgesic and anaesthetic agent that appears to exert a faster AD effect compared to traditional treatments, and to also be effective in treatment-resistant patients. Other ongoing preclinical and clinical studies aim to increase the increase the understanding of depression, and improve the diagnosis and treatment of our patients.

Recent research outputs

Jonas Broms, Grahm, M., Haugegaard, L., Thomas Blom, Meletis, K. & Anders Tingström 2017 Oct 15 In : Journal of Comparative Neurology. 525, 15, p. 3227-3250 24 p.

Research output: Contribution to journalArticle

Brus, O., Cao, Y., Gustafsson, E., Hultén, M., Landen, M., Lundberg, J., Nordanskog, P. & Nordenskjöld, A. 2017 Sep 1 In : European Psychiatry. 45, p. 154-160 7 p.

Research output: Contribution to journalArticle

Joakim Ekstrand & Pouya Movahed Rad 2017 Apr 24 In : Lakartidningen. 114, 17

Research output: Contribution to journalDebate/Note/Editorial

View All (50)